BioSpace News Archive

Businessman makes employee cuts as part of layoff

Layoffs

Arbutus Down to ‘Core Team’ After Laying Off More Than Half of Staff

Arbutus is also exiting its corporate headquarters in Pennsylvania and will terminate all in-house scientific research. The company’s focus is now an RNAi asset for hepatitis B.

March 28, 2025

·

2 min read

·

Tristan Manalac

Contemporary art collage. Conceptual image. Businessman catching money given by a hand. In search of profit. Concept of business, economy, financial growth, promotion, following

Obesity

‘There’s Only One Semaglutide’: Novo CEO Admits Compounders Are Hurting Weight Loss Business

Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen on Thursday, but the company hopes to win patients over.

March 28, 2025

·

1 min read

·

Annalee Armstrong

Different pills on seesaw weight scale. Comparison, choice, healthcare and medicine concept. Flat design. EPS 8 vector illustration, no transparency, no gradients

Cancer

Merck’s Injectable Keytruda Matches IV Formula in Pivotal Trial

Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s patent cliff at bay.

March 28, 2025

·

2 min read

·

Dan Samorodnitsky

Trendy halftone collage. Concept of contracting, negotiation, contracting, favorable terms. Trendy modern retro illustration on business theme. Concept of teamwork. Vector illustration

Obesity

Novo’s Obesity Pipeline Keeps Evolving With up to $1B Lexicon Deal

Lexicon’s LX9851 targets ACSL5, a liver enzyme involved in fat metabolism that helps moderate fat accumulation and slow down gastric emptying.

March 28, 2025

·

2 min read

·

Tristan Manalac

Wooden blocks with arrow and error icon. Delays and disruptions, stop the process, critical error concept

Alzheimer’s disease

EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi

The European Union’s CHMP said that the benefits of the drug, already approved in the U.S., do not outweigh the risk of potentially fatal brain swelling and bleeding.

March 28, 2025

·

2 min read

·

Dan Samorodnitsky

Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.

Cancer

BioNTech’s Bispecific Elicits Treatment Response in Majority of SCLC Patients

BNT327, a PD L1/VEGF antibody, belongs to a class of next-generation immunotherapies hoping to beat out Keytruda.

March 28, 2025

·

2 min read

·

Tristan Manalac

Heart rate cardiogram, heart rate indicators, EKG monitoring, electrocardiogram. The illustration is in red colors and the background is dark red with a grid.

Complete response letters

Milestone Stock Crashes After Surprise Tachycardia Drug Rejection

Milestone Pharmaceuticals hit another bump in the road in its quest to get Cardamyst approved for paroxysmal supraventricular tachycardia when the FDA issued a Complete Response Letter on Friday.

March 28, 2025

·

2 min read

·

Heather McKenzie

Press Releases

Marvel Biosciences Announces Private Placement

March 28, 2025

·

6 min read

Press Releases

Teva Releases Q1 2025 Aide Memoire